Galena Biopharma, Inc. (NASDAQ:GALE)

FDA_logo

7 Key FDA Decisions and Clinical Trial Results Coming in Q4

U.S. Food and Drug Administration (FDA) rulings and the results from clinical trials have proven time and again that they can make or break companies. The biotech and pharmaceutical companies ...
Read Full Story »
hammered

4 Companies That Destroyed Shareholders Despite a Brexit Recovery

Despite Brexit absolutely rocking the market over a week ago, the broad markets made a solid comeback leading most people to believe that this was just one big head fake. Some ...
Read Full Story »
Female patient on gurney

Is Galena Dead in the Water After This Failed Trial?

Galena Biopharma, Inc. (NASDAQ: GALE) is absolutely crashing on Wednesday after the company released further information regarding its Breast Cancer clinical trial. The company announced the recommendation from the Independent ...
Read Full Story »
biotech word cloud

8 Major Biopharma Events Coming Later in 2016 and in 2017

Companies in the pharmaceutical industry generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. There can be a fair amount of risk ...
Read Full Story »
buy sell

Top Wall Street Analyst Sell Ratings on High Profile Stocks This Week

At 24/7 Wall Street we have been running weekly research screens to scan the brokerage firms we cover for the stocks that are cut to Underperform or Sell ratings. The ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: BlackBerry, Care.com, Lululemon, Tesla, Veeco and More

Earnings season is now in the final phases, and investors and analysts are positioning themselves for the rest of 2014. Each morning, 24/7 Wall St. reviews dozens of Wall Street ...
Read Full Story »
$5

Eight Biotech Stocks Trading Near $5 With Huge Upside Potential

Often when a strong sell-off hits the stock market, the first stocks to go are the big momentum stocks that hedge funds often chase for performance and alpha. Right behind ...
Read Full Story »
buy sell

Ten Top Wall Street Analyst Stocks to Buy Trading Just Above or Below $5

Every quarter we like to review the research at the top firms we cover and look for any new stocks to buy that are priced either slightly above or under ...
Read Full Story »
biotech

Biotech Stocks Under $10 With Huge Upside Potential for 2014

Large cap biotech stocks have seen incredible stock performance over the past few years. The problem for many investors is that many of the key stocks have become so expensive ...
Read Full Story »
ten bucks

Ten Top Stocks Trading Under $10 to Buy for Big 2014 Gains

With less than a week left in what has been the best year for the S&P 500 since 1997, we have reviewed our top Wall Street firms for their stocks ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: FireEye, Fresh Market, Galena, Peabody and More

Stocks are challenging all-time highs, and this is a shortened week due to Thanksgiving. Investors have to start positioning their assets and portfolios for 2014. 24/7 Wall St. reviews dozens ...
Read Full Story »
biotech

New Top Stocks to Buy Under $10 with Big Upside

The Wall Street firms that handle the bulk of retail accounts are always very careful about recommending stocks priced in the single digits. Typically they are fallen angels, or sometimes ...
Read Full Story »
Wall St Bull statue

Top Analyst Upgrades and Stocks to Buy: Chesapeake, Citigroup, Monster and More

Investors and traders are always looking for new research ideas that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh research calls each morning to find ...
Read Full Story »
stock symbol ticker

Stock Market Today: Big Winners & Losers for Thursday

Here are the five biggest gaining stocks in today’s U.S. markets at closing: Imperial Holdings Inc. (NYSE: IFT) is up 40.5% at $5.59. Kingtone WirelessInfo Solution Holding Ltd. (NASDAQ: KONE) ...
Read Full Story »
Wall St Bull statue

12 Stocks Expected to Rise by 50% to 100% (or More) in 2013 (AMRN, CRZO, CNDO, EMKR, ETRM, EXAS, GALE, MX, OEDV, REGI, SPWR, SGYP)

It may seem hard to believe, but some stocks are expected to rise by 50%, 100%, or even more over the next year. Our own DJIA peak price target is ...
Read Full Story »